Shedding light on motor premanifest myotonic dystrophy type 1: A molecular, muscular and central nervous system follow‐up study

por Garmendia, Joana, Labayru, Garazi, Zulaica, Miren, Villanúa, Jorge, López de Munain, Adolfo, Sistiaga, Andone
Publicado 2022

White matter integrity changes and neurocognitive functioning in adult-late onset DM1: a follow-up DTI study

por Labayru, Garazi, Camino, Borja, Jimenez-Marin, Antonio, Garmendia, Joana, Villanua, Jorge, Zulaica, Miren, Cortes, Jesus M., López de Munain, Adolfo, Sistiaga, Andone
Publicado 2022

Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges

por Saenz-Antoñanzas, Ander, Auzmendi-Iriarte, Jaione, Carrasco-Garcia, Estefania, Moreno-Cugnon, Leire, Ruiz, Irune, Villanua, Jorge, Egaña, Larraitz, Otaegui, David, Samprón, Nicolás, Matheu, Ander
Publicado 2019

Neurodegeneration trajectory in pediatric and adult/late DM1: A follow‐up MRI study across a decade

por Labayru, Garazi, Jimenez‐Marin, Antonio, Fernández, Esther, Villanua, Jorge, Zulaica, Miren, Cortes, Jesus M., Díez, Ibai, Sepulcre, Jorge, López de Munain, Adolfo, Sistiaga, Andone
Publicado 2020

Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital

por Egaña, Larraitz, Auzmendi-Iriarte, Jaione, Andermatten, Joaquin, Villanua, Jorge, Ruiz, Irune, Elua-Pinin, Alejandro, Aldaz, Paula, Querejeta, Arrate, Sarasqueta, Cristina, Zubia, Felix, Matheu, Ander, Samprón, Nicolas
Publicado 2020

Targeting SOX2 as a Therapeutic Strategy in Glioblastoma

por Garros-Regulez, Laura, Garcia, Idoia, Carrasco-Garcia, Estefania, Lantero, Aquilino, Aldaz, Paula, Moreno-Cugnon, Leire, Arrizabalaga, Olatz, Undabeitia, Jose, Torres-Bayona, Sergio, Villanua, Jorge, Ruiz, Irune, Egaña, Larraitz, Sampron, Nicolas, Matheu, Ander
Publicado 2016

mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance

por Garros-Regulez, Laura, Aldaz, Paula, Arrizabalaga, Olatz, Moncho-Amor, Veronica, Carrasco-Garcia, Estefania, Manterola, Lorea, Moreno-Cugnon, Leire, Barrena, Cristina, Villanua, Jorge, Ruiz, Irune, Pollard, Steven, Lovell-Badge, Robin, Sampron, Nicolas, Garcia, Idoia, Matheu, Ander
Publicado 2016

PR-LncRNA signature regulates glioma cell activity through expression of SOX factors

por Torres-Bayona, Sergio, Aldaz, Paula, Auzmendi-Iriarte, Jaione, Saenz-Antoñanzas, Ander, Garcia, Idoia, Arrazola, Mariano, Gerovska, Daniela, Undabeitia, Jose, Querejeta, Arrate, Egaña, Larraitz, Villanúa, Jorge, Ruiz, Irune, Sarasqueta, Cristina, Urculo, Enrique, Araúzo-Bravo, Marcos J., Huarte, Maite, Samprón, Nicolas, Matheu, Ander
Publicado 2018

Functional brain network centrality is related to APOE genotype in cognitively normal elderly

por Wink, Alle Meije, Tijms, Betty M., ten Kate, Mara, Raspor, Eva, de Munck, Jan C., Altena, Ellemarije, Ecay‐Torres, Mirian, Clerigue, Montserrat, Estanga, Ainara, Garcia‐Sebastian, Maite, Izagirre, Andrea, Martinez‐Lage Alvarez, Pablo, Villanua, Jorge, Barkhof, Frederik, Sanz‐Arigita, Ernesto
Publicado 2018

Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors

por Torres-Bayona, Sergio, Aldaz, Paula, Auzmendi-Iriarte, Jaione, Saenz-Antoñanzas, Ander, Garcia, Idoia, Arrazola, Mariano, Gerovska, Daniela, Undabeitia, Jose, Querejeta, Arrate, Egaña, Larraitz, Villanúa, Jorge, Ruiz, Irune, Sarasqueta, Cristina, Urculo, Enrique, Araúzo-Bravo, Marcos J., Huarte, Maite, Samprón, Nicolas, Matheu, Ander
Publicado 2022